Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXW9X3
|
||||
Drug Name |
[3-(2-Chloro-benzoylamino)-5-(2-fluoro-phenyl)-2-oxo-2,3-dihydro-benzo[e][1,4]diazepin-1-yl]-acetic acid ethyl ester
|
||||
Synonyms |
CHEMBL72546
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H21ClFN3O4
|
||||
Canonical SMILES |
CCOC(=O)CN1C(=O)C(NC(=O)c2ccccc2Cl)N=C(c3ccccc3F)c4ccccc14
|
||||
InChI |
InChI=1S/C26H21ClFN3O4/c1-2-35-22(32)15-31-21-14-8-5-11-18(21)23(17-10-4-7-13-20(17)28)29-24(26(31)34)30-25(33)16-9-3-6-12-19(16)27/h3-14,24H,2,15H2,1H3,(H,30,33)
|
||||
InChIKey |
ZECBJKKPSULHJR-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.